Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Dermatology indexChapter sections
OverviewAetiologyPathophysiologyClinical features and red flagsInvestigationsDifferential diagnosisManagementComplicationsMonitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook13 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Skin signs of systemic disease

Dermatology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

Escalate immediately for non-blanching purpura with systemic illness, painful retiform skin with organ dysfunction, extensive blistering or detachment, suspected adrenal crisis, severe vasculitis, or signs of infective endocarditis with sepsis.

Overview

Recognise cutaneous clues to internal disease, separate common benign findings from time-critical syndromes, and investigate the whole clinical pattern rather than a skin sign in isolation.

Systemic illness can alter vessels, circulating cells, immune signalling, hormones and tissue deposition. The useful unit is a syndrome: morphology plus distribution, tempo, symptoms and non-cutaneous findings. Splinter haemorrhages alone are common after trauma; splinter haemorrhages with fever, murmur and embolic features have different significance.

Examine the whole patient with consent. Record vital signs, blanching, tenderness and necrosis; inspect oral and ocular mucosae, hair, nails and lymph nodes; test urine when vasculitis or endocarditis is plausible. Choose blood tests from the pattern rather than ordering indiscriminate autoimmune or tumour panels.

Skin signs of systemic disease should answer a defined clinical question and be integrated with history, examination and the consequences of error. Explain uncertainty, record the sampling or observation conditions, and arrange a result-review plan rather than treating an isolated finding as self-interpreting.

Key points

  • A skin sign is a clue, not a diagnosis: integrate onset, symptoms, medicines, physiology, mucosae, nails, nodes and organ-specific findings.
  • Non-blanching petechiae or purpura in an unwell patient requires urgent assessment for infection, thrombocytopenia, coagulopathy and vasculitis.
  • Generalised pigmentation involving creases, scars or oral mucosa with weakness, weight loss and postural dizziness supports primary adrenal insufficiency.
  • Acanthosis nigricans commonly tracks insulin resistance; abrupt extensive disease with weight loss or mucosal involvement needs broader assessment.
  • For Skin signs of systemic disease, describe what is seen before assigning a diagnosis, and record site, extent, symptoms, duration and change over time.
  • A technically adequate result in Skin signs of systemic disease can still be misleading when the wrong lesion, site, preparation or clinical question was selected.

Aetiology

01

Vascular and haematological disease

Thrombocytopenia, coagulopathy, emboli, vasculitis and occlusive vasculopathy produce petechiae, purpura, livedoid change, infarction or painful ulceration through different mechanisms.

02

Endocrine and metabolic disease

Hormonal deficiency or excess, hepatic or renal dysfunction, nutritional deficiency and abnormal circulating metabolites alter pigment, texture, pruritus, hair and nails.

03

Immune and malignant signalling

Autoimmune inflammation, infection and paraneoplastic mediators can create characteristic eruptions, but most individual signs remain probabilistic rather than diagnostic.

Pathophysiology

  1. 1
    Blood outside vessels

    Petechiae and purpura arise when erythrocytes escape into skin because of platelet failure, vessel inflammation, trauma or coagulation disturbance and therefore do not blanch.

  2. 2
    Microvascular compromise

    Embolic, thrombotic or inflammatory occlusion reduces dermal perfusion, causing livedoid networks, severe pain, necrosis and potential parallel injury in kidneys, brain or other organs.

  3. 3
    Systemic pigment signalling

    Increased ACTH can stimulate melanocortin receptors in primary adrenal insufficiency, producing diffuse pigmentation that may involve creases, scars and oral mucosa.

  4. 4
    Deposition and inflammation

    Metabolic products, immune complexes or malignant cytokines alter dermal structure and inflammatory recruitment, linking visible change with an internal disease process.

Clinical features and red flags

Purpura with illnessRed flag

Rapidly evolving non-blanching lesions plus fever, hypotension or altered consciousness can indicate invasive infection or severe haematological disease.

Retiform painful changeRed flag

Branching angulated purpura, livedoid change and pain out of proportion suggest vessel occlusion or vasculopathy with possible organ threat.

Adrenal pigmentation syndrome

Diffuse darkening of creases, scars and mucosa with fatigue, weight loss, salt craving or postural symptoms supports adrenal insufficiency.

Connective-tissue pattern

Photosensitive eruption, oral ulceration, Raynaud phenomenon, nail-fold change, proximal weakness or sclerodactyly should prompt phenotype-led autoimmune assessment.

Malignant warning constellation

Abrupt unusual dermatosis with weight loss, lymphadenopathy, organ symptoms or treatment resistance warrants examination beyond the skin.

Red flags requiring action

  • Fever, hypotension, altered mental state, breathlessness, rapidly evolving purpura, mucosal injury, unexplained weight loss or acute kidney findings make a systemic skin sign urgent.

Investigations

  1. 01
    ABCDE assessment and observationsFirst step
    Why
    Identify sepsis, shock, respiratory failure or adrenal crisis before diagnostic refinement.
    Interpretation and limitations
    Abnormal physiology determines urgency even when colour change is subtle; stable observations do not erase rapidly progressive skin pain or necrosis.
  2. 02
    FBC, film, coagulation and inflammatory markers
    Why
    Assess cytopenia, haemolysis, coagulation failure and systemic inflammation.
    Interpretation and limitations
    Interpret values with medicines, infection and organ function; a normal platelet count does not exclude vasculitis or platelet dysfunction.
  3. 03
    Urinalysis, renal, liver and endocrine testing
    Why
    Detect internal involvement suggested by the cutaneous syndrome.
    Interpretation and limitations
    Haematuria and proteinuria can mark systemic vasculitis; electrolyte patterns and cortisol pathways require emergency interpretation when adrenal crisis is possible.
  4. 04
    Skin biopsy with appropriate adjuncts
    Why
    Classify selected inflammatory, infiltrative or vascular lesions.
    Interpretation and limitations
    Choose a fresh lesion and sufficient depth; histology may need direct immunofluorescence, culture or haematological studies arranged separately.

Differential diagnosis

01

Benign local trauma

Pressure, minor injury, senile purpura and medication-related bruising may explain local lesions, but distribution and systemic context must remain compatible.

02

Primary skin disease

Eczema, psoriasis, infection and pigmentary disorders often coexist with internal disease and should not automatically be interpreted as paraneoplastic or autoimmune.

03

Systemic infection or vasculitis

Fever, rapidly spreading non-blanching lesions, neuropathy, haematuria or organ dysfunction shifts assessment toward time-critical infectious or inflammatory vascular disease.

04

Haematological malignancy

Persistent unexplained bruising, pallor, lymphadenopathy, constitutional symptoms or infiltrated plaques warrants a blood count, examination and directed specialist assessment.

Management

01Planned assessmentUse systemic dermatological examination systematicallyFirst stepThe patient is stable and the result will alter diagnosis, referral or follow-up.+
  1. 1Define the question for Skin signs of systemic disease, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
  2. 2Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
  3. 3Interpret the result beside the full clinical pattern, communicate uncertainty and arrange ownership of results and safety-netting. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
02Uncertain resultResolve discordance in Skin signs of systemic diseaseThe technical finding conflicts with the history, lesion evolution or wider examination.+

Complications

01

Missed physiological collapse

Treating purpura or pigmentation as an isolated dermatological issue can delay resuscitation for sepsis, adrenal crisis, bleeding or microvascular organ injury.

02

Irreversible tissue loss

Occlusive vasculopathy and severe vasculitis may progress from pain and retiform colour change to necrosis, neuropathy, renal failure or limb-threatening damage.

03

Delayed internal diagnosis

Failure to connect a reproducible skin syndrome with systemic symptoms can postpone recognition of endocrine, hepatic, renal, autoimmune, infectious or malignant disease.

Monitoring and follow-up

  • Record who will review the result arising from Skin signs of systemic disease, the expected timescale and the action threshold before the patient leaves.
  • Compare subsequent findings with the original site description, dimensions, symptoms and image or specimen identifiers for Skin signs of systemic disease.
  • Reassess earlier if rapid growth, bleeding, ulceration, fever, mucosal disease, eye symptoms or functional compromise develops. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
  • Document technical limitations and previous treatment that could alter sensitivity or specificity of systemic dermatological examination.
  • Close the loop after specialist or laboratory review, including clinicopathological disagreement and any need for repeat sampling. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.

Special situations

Non-blanching is a mechanism

It indicates blood outside vessels but does not distinguish trauma, platelet disease, sepsis or vasculitis.

Pain can precede necrosis

Severe tenderness in retiform or dusky skin may signal vascular compromise before visible tissue loss develops.

Common signs need context

Clubbing, acanthosis and splinter haemorrhages each have benign and serious associations; chronology and accompanying findings set probability.

Mucosa reveals systemic pigment

Oral pigmentation can help distinguish generalised endocrine change from sun exposure or local post-inflammatory colour.

Biopsy timing matters

A fresh purpuric or inflammatory lesion may preserve diagnostic vessel changes lost in a late necrotic centre.

Common pitfalls

  1. 01

    Reassuring an unwell patient because a purpuric rash is small or difficult to appreciate.

  2. 02

    Ordering broad autoimmune panels for one nonspecific lesion without urine, physiology or clinical phenotype.

  3. 03

    Calling abrupt acanthosis nigricans malignant without assessing common metabolic causes and genuine warning features.

  4. 04

    Biopsying the dead centre of a large necrotic lesion when an active edge is more informative.

  5. 05

    Failing to ask about anticoagulants, corticosteroids, immunotherapy and new medicines that reshape systemic differentials.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
DermatologyOriginal SBA

Purpura and systemic illness

A febrile patient is confused and hypotensive with a rapidly developing non-blanching rash. What is the immediate priority?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Dermatology topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS meningitis symptomsEmergency recognition of non-blanching rash with systemic illness.
  • NHS Addison disease symptomsSystemic symptoms accompanying characteristic pigmentation change.
  • Guy's and St Thomas' NHS Foundation Trust skin biopsySkin-biopsy preparation, procedure, aftercare and result follow-up.
  • NICE NG12 suspected cancer recognition and referralUrgent referral features for suspected skin malignancy.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
  • 05
    Targeted imaging or specialist tests
    Why
    Investigate suspected internal infection, malignancy or organ disease.
    Interpretation and limitations
    Echocardiography, cross-sectional imaging and serology follow defined clinical hypotheses and should not be driven by an isolated nonspecific sign.
    1. 1Recheck identity, site, timing, preparation, treatment exposure and whether the selected target was genuinely representative. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
    2. 2Repeat or select a complementary test only when it can distinguish the remaining important alternatives. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
    3. 3Seek dermatology, pathology, microbiology or allergy advice when clinicopathological disagreement would change urgent care. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
    03Urgent patternDo not let systemic dermatological examination delay escalationEscalationA rapidly progressive eruption, systemic illness, threatened vision or airway, or suspected aggressive malignancy is present. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.+
    1. 1Stabilise immediate physiological threats and obtain same-day senior or specialty assessment according to the dominant emergency. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
    2. 2DefinitiveTake time-critical images or specimens only when doing so will not postpone resuscitation, antimicrobials or definitive referral. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
    3. 3Record evolution and communicate the differential, outstanding results and explicit deterioration triggers during handover. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.